Define range intervals using parentheses.
E.g. C7H(10-14)O(0-4)

to
±
(example: 123 ± 1)

to
±

to
±
 

to
±
 
Search Hits Limit:
Single/Multi-component
Isotopically Labeled
Additional Filters

Found 670 results

Search term: MF = 'C_{33}H_{32}N_{4}O_{4}'
12345
IDStructureMolecular FormulaMolecular Weight# of Data Sources# of References# of PubMed# of RSC
9413190

2 of 2 defined stereocentres - 2/2 defined
InChI=1/C33H32N4O4/c38-27-15-13-23(14-16-27)19-29-32(40)35(21-26-11-6-10-25-9-4-5-12-28(25)26)22-30-36(18-17-31(39)37(29)30)33(41)34-20-24-7-2-1-3-8-24/h1-16,29-30,38H,17-22H2,(H,34,41)/t29-,30+/m0/s1
C33H32N4O4548.6316766400
19546236

0 of 2 defined stereocentres - 0/2 defined
InChI=1/C33H32N4O4/c38-27-15-13-23(14-16-27)19-29-32(40)35(21-26-11-6-10-25-9-4-5-12-28(25)26)22-30-36(18-17-31(39)37(29)30)33(41)34-20-24-7-2-1-3-8-24/h1-16,29-30,38H,17-22H2,(H,34,41)
C33H32N4O4548.6316202400
3923960

0 of 1 defined stereocentres - 0/1 defined
InChI=1/C33H32N4O4/c1-21-13-16-26(17-14-21)37-33(24-15-18-29(40-4)30(19-24)41-5)36(31(35-37)23(3)38)27-11-8-10-25(20-27)34-32(39)28-12-7-6-9-22(28)2/h6-20,33H,1-5H3,(H,34,39)
C33H32N4O4548.631617900
3662786

0 of 1 defined stereocentres - 0/1 defined
InChI=1/C33H32N4O4/c1-20-29(32(39)37-28-7-5-6-14-35-28)30(31-25(36-20)16-33(2,3)17-26(31)38)22-10-13-27(40-4)23(15-22)19-41-24-11-8-21(18-34)9-12-24/h5-15,30,36H,16-17,19H2,1-4H3,(H,35,37,39)
C33H32N4O4548.631579999998161100
7908699

Double-bond stereo
InChI=1/C33H32N4O4/c1-40-31-10-6-5-9-30(31)37-21-19-36(20-22-37)24-26-11-15-27(16-12-26)32(38)35-34-23-25-13-17-29(18-14-25)41-33(39)28-7-3-2-4-8-28/h2-18,23H,19-22,24H2,1H3,(H,35,38)/b34-23+
C33H32N4O4548.6316151000
9470771

1 of 2 defined stereocentres - 1/2 defined
InChI=1/C33H32N4O4/c38-27-15-13-23(14-16-27)19-29-32(40)35(21-26-11-6-10-25-9-4-5-12-28(25)26)22-30-36(18-17-31(39)37(29)30)33(41)34-20-24-7-2-1-3-8-24/h1-16,29-30,38H,17-22H2,(H,34,41)/t29-,30?/m0/s1
C33H32N4O4548.6316141300
4365317

0 of 1 defined stereocentres - 0/1 defined
InChI=1/C33H32N4O4/c1-21-17-27(23(3)36(21)19-26-15-10-16-40-26)30(38)20-41-33(39)28-18-29(24-11-6-4-7-12-24)34-32-31(28)22(2)35-37(32)25-13-8-5-9-14-25/h4-9,11-14,17-18,26H,10,15-16,19-20H2,1-3H3
C33H32N4O4548.63157999999812800
17470158

1 of 2 defined stereocentres - 1/2 defined
InChI=1/C33H32N4O4/c1-41-24-11-7-8-21(18-24)30-29-26(25-12-5-6-13-27(25)35-29)19-28-32(39)36(33(40)37(28)30)23-16-14-20(15-17-23)31(38)34-22-9-3-2-4-10-22/h5-8,11-18,22,28,30,35H,2-4,9-10,19H2,1H3,(H,34,38)/t28-,30?/m0/s1
C33H32N4O4548.631611800
17470211

1 of 2 defined stereocentres - 1/2 defined
InChI=1/C33H32N4O4/c1-41-24-17-13-20(14-18-24)30-29-26(25-9-5-6-10-27(25)35-29)19-28-32(39)36(33(40)37(28)30)23-15-11-21(12-16-23)31(38)34-22-7-3-2-4-8-22/h5-6,9-18,22,28,30,35H,2-4,7-8,19H2,1H3,(H,34,38)/t28-,30?/m0/s1
C33H32N4O4548.631611900
17470284

1 of 2 defined stereocentres - 1/2 defined
InChI=1/C33H32N4O4/c1-41-22-13-9-10-20(18-22)30-29-25(23-14-5-7-16-26(23)35-29)19-28-32(39)37(33(40)36(28)30)27-17-8-6-15-24(27)31(38)34-21-11-3-2-4-12-21/h5-10,13-18,21,28,30,35H,2-4,11-12,19H2,1H3,(H,34,38)/t28-,30?/m0/s1
C33H32N4O4548.631611800
17470360

1 of 2 defined stereocentres - 1/2 defined
InChI=1/C33H32N4O4/c1-41-22-17-15-20(16-18-22)30-29-25(23-11-5-7-13-26(23)35-29)19-28-32(39)37(33(40)36(28)30)27-14-8-6-12-24(27)31(38)34-21-9-3-2-4-10-21/h5-8,11-18,21,28,30,35H,2-4,9-10,19H2,1H3,(H,34,38)/t28-,30?/m0/s1
C33H32N4O4548.631611800
17470737

2 of 4 defined stereocentres - 2/4 defined
InChI=1/C33H32N4O4/c38-31(34-19-21-11-8-16-41-21)27(17-20-9-2-1-3-10-20)36-32(39)28-18-25-22-12-6-7-15-26(22)35-29(25)30-23-13-4-5-14-24(23)33(40)37(28)30/h1-7,9-10,12-15,21,27-28,30,35H,8,11,16-19H2,(H,34,38)(H,36,39)/t21?,27-,28-,30?/m0/s1
C33H32N4O4548.631610900
1384862

3 of 3 defined stereocentres - 3/3 defined
InChI=1/C33H32N4O4/c38-31-13-7-12-30-25-18-24(21-37(30)31)20-36(22-25)33(40)35-29(19-23-8-3-1-4-9-23)32(39)34-26-14-16-28(17-15-26)41-27-10-5-2-6-11-27/h1-17,24-25,29H,18-22H2,(H,34,39)(H,35,40)/t24-,25+,29+/m1/s1
C33H32N4O4548.6316101100
4099978

0 of 4 defined stereocentres - 0/4 defined
InChI=1/C33H32N4O4/c1-20(2)18-24-28-29(31(40)37(30(28)39)22-11-4-3-5-12-22)33(34-24)23-13-7-9-15-26(23)36(32(33)41)19-27(38)35-17-16-21-10-6-8-14-25(21)35/h3-15,20,24,28-29,34H,16-19H2,1-2H3
C33H32N4O4548.63157999999810500
22243676
InChI=1/C33H32N4O4/c1-21-8-5-6-9-26(21)30-23(18-27-28(35-30)19-29(39-2)32(41-4)31(27)40-3)20-36(24-14-15-24)33(38)22-10-12-25(13-11-22)37-17-7-16-34-37/h5-13,16-19,24H,14-15,20H2,1-4H3
C33H32N4O4548.63169700
57618331

2 of 2 defined stereocentres - 2/2 defined
InChI=1/C33H32N4O4/c38-27-15-13-23(14-16-27)19-29-32(40)35(21-26-11-6-10-25-9-4-5-12-28(25)26)22-30-36(18-17-31(39)37(29)30)33(41)34-20-24-7-2-1-3-8-24/h1-16,29-30,38H,17-22H2,(H,34,41)/t29-,30+/m1/s1
C33H32N4O4548.63169700
30808244

Double-bond stereo
InChI=1/C33H32N4O4/c1-5-41-32(40)26-21-25-28(34-27-13-9-10-19-36(27)31(25)39)37(20-18-22-11-7-6-8-12-22)29(26)35-30(38)23-14-16-24(17-15-23)33(2,3)4/h6-17,19,21H,5,18,20H2,1-4H3/b35-29-
C33H32N4O4548.63168600
13131132

0 of 2 defined stereocentres - 0/2 defined
InChI=1/C33H32N4O4/c1-40-25-14-10-23(11-15-25)31-30(33(39)36-21-19-35(20-22-36)29-9-5-6-18-34-29)27-7-3-4-8-28(27)32(38)37(31)24-12-16-26(41-2)17-13-24/h3-18,30-31H,19-22H2,1-2H3
C33H32N4O4548.63168700
22611519
InChI=1/C33H32N4O4/c1-23(2)24-14-16-27(17-15-24)37-21-30(25-9-5-4-6-10-25)34-33(37)35-31(38)22-36(20-29-13-8-18-41-29)32(39)26-11-7-12-28(19-26)40-3/h4-19,21,23H,20,22H2,1-3H3,(H,34,35,38)
C33H32N4O4548.63167600
22644112
InChI=1/C33H32N4O4/c1-23(2)25-11-15-27(16-12-25)37-21-29(26-13-17-28(40-3)18-14-26)34-33(37)35-31(38)22-36(20-24-8-5-4-6-9-24)32(39)30-10-7-19-41-30/h4-19,21,23H,20,22H2,1-3H3,(H,34,35,38)
C33H32N4O4548.63167600
12345

Advertisement